AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2026
Feb 13, 2026
31676_dirs_2026-02-13_4d232364-1674-4200-99bf-ec1ed5510e7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2026-02-11
Reporting Person: CAREY STEPHEN P. (SVP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-11 | Common Stock | F | 5503 | $76.25 | Disposed | 175360 | Direct |
Footnotes
F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units, the grant of which was previously reported on April 6, 2023.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3